Fmr LLC Gritstone Bio, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Fmr LLC holds 1,608,371 shares of GRTS stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,608,371

Previous 1,043,903 54.07%

Holding current value

$1.01 Million

Previous $2.68 Million 62.83%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.62 - $2.35 $349,970 - $1.33 Million	564,468 Added 54.07%	1,608,371 $997,000
Q1 2024 May 13, 2024	SELL	$1.96 - $2.9 $1.85 Million - $2.73 Million	-941,391 Reduced 47.42%	1,043,903 $2.68 Million
Q4 2023 Feb 13, 2024	BUY	$1.28 - $2.85 $1.45 Million - $3.23 Million	1,131,696 Added 132.58%	1,985,294 $4.05 Million
Q3 2023 Nov 13, 2023	BUY	$1.19 - $2.26 $75,305 - $143,017	63,282 Added 8.01%	853,598 $1.47 Million
Q2 2023 Aug 11, 2023	SELL	$1.66 - $3.03 $13,607 - $24,836	-8,197 Reduced 1.03%	790,316 $1.54 Million
Q1 2023 May 11, 2023	BUY	$2.13 - $3.74 $17,169 - $30,148	8,061 Added 1.02%	798,513 $2.22 Million
Q4 2022 Feb 13, 2023	BUY	$2.17 - $3.92 $430,185 - $777,108	198,242 Added 33.47%	790,452 $2.73 Million
Q3 2022 Nov 10, 2022	SELL	$2.46 - $4.75 $974 - $1,881	-396 Reduced 0.07%	592,210 $1.52 Million
Q2 2022 Aug 12, 2022	BUY	$1.77 - $4.34 $802,344 - $1.97 Million	453,302 Added 325.4%	592,606 $1.43 Million
Q1 2022 May 13, 2022	SELL	$4.03 - $12.19 $7.77 Million - $23.5 Million	-1,928,847 Reduced 93.26%	139,304 $574,000
Q4 2021 Feb 14, 2022	SELL	$8.76 - $13.71 $8.62 Million - $13.5 Million	-983,707 Reduced 32.23%	2,068,151 $26.6 Million
Q3 2021 Nov 15, 2021	BUY	$6.41 - $13.54 $1.64 Million - $3.47 Million	256,445 Added 9.17%	3,051,858 $33 Million
Q2 2021 Aug 13, 2021	BUY	$8.13 - $10.2 $22.7 Million - $28.5 Million	2,795,413 New	2,795,413 $25.5 Million

Others Institutions Holding GRTS

# of Institutions

Shares Held

37.5M

Call Options Held

1.46M

Put Options Held

168K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $46M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account